N-(4,4'-Dibromo-[1,1'-biphen-yl]-2-yl)benzamide.

Acta Crystallogr Sect E Struct Rep Online

Department of Physics, Idhaya College for Women, Kumbakonam-1, India.

Published: February 2013

AI Article Synopsis

Article Abstract

In the title compound, C(19)H(13)Br(2)NO, the dihedral angle between the rings of the biphenyl group is 53.59 (14)°. The ring of the benzamide group is inclined to the phenyl rings of the biphenyl group by 23.87 (15) and 75.89 (15)°. There are no significant inter-molecular inter-actions in the crystal structure.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569757PMC
http://dx.doi.org/10.1107/S1600536813000597DOI Listing

Publication Analysis

Top Keywords

rings biphenyl
8
biphenyl group
8
n-44'-dibromo-[11'-biphen-yl]-2-ylbenzamide title
4
title compound
4
compound c19h13br2no
4
c19h13br2no dihedral
4
dihedral angle
4
angle rings
4
group 5359 14°
4
5359 14° ring
4

Similar Publications

Contamination of chars with dioxin-like polychlorinated biphenyls (dl-PCB) significantly limits their use and hinders their deployment in the circular bioeconomy, specifically in applications that may lead to dietary exposure. Here, for the first time, we review the levels of contamination of chars produced from pyrolysis and hydrothermal carbonisation (HTC) with dl-PCB congeners. We conduct a detailed and critical examination of the role played by the processing parameters, such as temperature and residence time, and the reaction mechanisms, to detoxify the biomass under an oxygen-free atmosphere during its valorisation.

View Article and Find Full Text PDF

Lipid droplets (LDs) are dynamic, multifunctional organelles critical for regulating energy balance, cell signaling, membrane formation, and trafficking. Recent studies have highlighted LDs as emerging cancer biomarkers, with cancer cells typically exhibiting a higher number and viscosity of LDs compared to normal cells. This discovery paves the way for developing molecular probes that can monitor intracellular viscosity changes within LDs, offering a powerful tool for early cancer diagnosis, recurrence monitoring, and therapeutic interventions.

View Article and Find Full Text PDF

Circumventing Imatinib resistance in CML: Novel Telmisartan-based cell death modulators with improved activity and stability.

Eur J Med Chem

February 2025

Department of Internal Medicine V, Hematology and Oncology, Tyrolean Cancer Research Institute (TKFI), Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria. Electronic address:

Drug resistance presents a significant challenge in cancer therapy, which has led to intensive research in resistance mechanisms and new therapeutic strategies. In chronic myeloid leukemia (CML), the introduction of Imatinib, the first tyrosine kinase inhibitor (TKI), drastically changed the outcome for patients. However, complete remission still cannot be achieved in a large number of patients in the long term.

View Article and Find Full Text PDF

A focussed library of pyridyl and 2-hydroxyphenyl chalcones were synthesized and tested for growth inhibitory activity against H37Rv, and normal and cancer breast cell lines. Pyridyl chalcones bearing lipophilic A-ring, e.g.

View Article and Find Full Text PDF

In the title compound, CHON, the dihedral angle between the aromatic rings of the biphenyl unit is 38.14 (2)° and the C-O-C-C torsion angle in the benz-yloxy benzene fragment is 179.1 (2)°.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!